Literature DB >> 24589541

Evidence to support use of palonosetron over generic serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting.

Yu-Chen Yeh1, Gayle C Blouin, Prabashni Reddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24589541     DOI： 10.2146/ajhp130394

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

Review 1.  Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.

Authors:  Rudolph M Navari
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 2.  Serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting: therapeutically equivalent or meaningfully different?

Authors:  Jill M Kolesar; Jens Eickhoff; Lee C Vermeulen
Journal:  Am J Health Syst Pharm       Date:  2014-03-15       Impact factor: 2.637

Review 3.  Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.

Authors:  Mary Lou Affronti; Joseph Bubalo
Journal:  Cancer Manag Res       Date:  2014-09-05       Impact factor: 3.989

Review 4.  Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists.

Authors:  James Gilmore; Steven D'Amato; Niesha Griffith; Lee Schwartzberg
Journal:  Cancer Manag Res       Date:  2018-07-03       Impact factor: 3.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.